Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between LEP and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication.

Psychiatric genetics - 1 Dec 2010

Gregoor Jochem G, van der Weide Jan, Loovers Harriet M, van Megen Harold J, Egberts Toine C, Heerdink Eibert R

Abstract excerpt

BACKGROUND: Treatment with atypical antipsychotic agents is often complicated by dyslipidemia, which is a risk factor for cardiovascular disease. OBJECTIVES: To determine whether the LEPR Q223R, the LEP -2548G/A, and the HTR2C -759C/T polymorphisms are associated with dyslipidemia in patients using atypical antipsychotic drugs. METHODS: A cross-sectional study design was used. The study population included all...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol

Share to Dyslipidemias

Share to Genetic Association Studies

Share to Leptin

Share to Lipoproteins, HDL

Share to Receptors, Leptin

Source

Identifiers

PMID: 20562674
DOI: 10.1097/YPG.0b013e32833b6378

Genes

LEP
LEPR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between LEP and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication.PMID 20562674Read ↗

Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.Semantic proximity Read ↗

Genetic polymorphisms of HTR2C, LEP and LEPR on metabolic syndromes in patients treated with atypical antipsychotic drugs.Semantic proximity Read ↗

Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting.Semantic proximity Read ↗

Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication.Semantic proximity Read ↗

LEPR gene polymorphisms and pneumonia risk in Taiwanese schizophrenia patients under clozapine treatment.Semantic proximity Read ↗

Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic DrugsSemantic proximity Read ↗

Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin.Semantic proximity Read ↗

Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics.Semantic proximity Read ↗

Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.Semantic proximity Read ↗

The effect of leptin promoter and leptin receptor gene polymorphisms on lipid profile among the diabetic population: modulations by atorvastatin treatment and environmental factors.Semantic proximity Read ↗

Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.Semantic proximity Read ↗

Association between schizophrenia and single nucleotide polymorphisms in lipoprotein lipase gene in a Han Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.